Solventum Corp SOLV

Morningstar Rating
$76.70 +0.74 (0.97%)
View Full Chart

Company Report

Solventum Seeks to Chart Its Own Path, Improve Operations, and Raise Profitability

After being spun out in spring 2024, Solventum is set to chart its own course and now faces challenges to operate as a stand-alone company. It has laid out a methodical strategic path to juggle several priorities as it gets on its feet. First, management has been engaged in evaluating the end markets that Solventum currently competes in and assessing the relative strength of its product portfolio. We expect this process will result in significant restructuring. We applaud the firm’s early decision to sell its purification and filtration business. Not only did this offer Solventum an exit from a business with materially lower margins than the other three divisions, but the proceeds should help mitigate the company’s significant leverage since the spinoff.

Price vs Fair Value

SOLV is trading at a LOCK|<<gT@m& premium.
Price
$76.70
Fair Value
d<R
Uncertainty
LOCK|^>vH$
1-Star Price
LOCK|.jBx
5-Star Price
LOCK|.d
Economic Moat
LOCK|y$N
Capital Allocation
LOCK|QwC%D#W

Bulls Say, Bears Say

Bulls

CEO Bryan Hanson and CFO Wayde McMillan are both highly seasoned leaders with solid records at Covidien, Medtronic, Zimmer Biomet, and Insulet.

Bears

Many of Solventum’s medsurg products are sold to group purchasing organizations, where there is more price pressure than with highly engineered physician preference items marketed directly to doctors.

News

Trading Information

Previous Close Price
$75.96
Day Range
$75.2676.97
52-Week Range
$62.3888.20
Bid/Ask
$70.00 / $79.50
Shares Outstanding
173.17M
Market Cap
$13.28B
Volume/Avg
532,938 / 2M

Key Statistics

Price/Earnings (Normalized)
12.28
Price/Sales
1.62
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Total Yield

Company Profile

Solventum Corp is a healthcare company developing, manufacturing, and commercializing solutions leveraging material science, data science, and digital capabilities to address customer and patient needs. Its segments include MedSurg, which earns maximum revenue and provides wound therapy, I.V. site management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and OEM medical technologies; Dental Solutions, offering dental and orthodontic products such as brackets, restorative cements, and bonding agents; and Health Information Systems, providing software solutions including physician documentation, coding automation, speech recognition, and data visualization platforms. It operates in the United States, which earns the majority of revenue, and internationally.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Small Core
Total Number of Employees
20,000

Competitors

Valuation

Metric
SOLV
ORCL
COLO B
Price/Earnings (Normalized)
12.2818.5639.24
Price/Book Value
2.6610.867.13
Price/Sales
1.626.133.27
Price/Cash Flow
28.2414.8211.76
Price/Earnings
SOLV
ORCL
COLO B

Financial Strength

Metric
SOLV
ORCL
COLO B
Quick Ratio
0.521.011.01
Current Ratio
1.071.121.75
Interest Coverage
6.545.084.40
Quick Ratio
SOLV
ORCL
COLO B

Profitability

Metric
SOLV
ORCL
COLO B
Return on Assets (Normalized)
7.61%10.48%10.99%
Return on Equity (Normalized)
25.01%76.33%34.77%
Return on Invested Capital (Normalized)
12.75%15.95%14.97%
Return on Assets
SOLV
ORCL
COLO B

Medical Instruments & Supplies Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
LOCK|kJqL>%XLOCK|#C$144B
Becton Dickinson & Co
BDX
LOCK|N%DLOCK|C&sJ$42B
Medline Inc Ordinary Shares - Class A
MDLN
LOCK|V?&w!^gLOCK|@t^F$35B
Alcon Inc
ALC
LOCK|!sF?RGLOCK|^H&%@$33B
ResMed Inc
RMD
LOCK|CH!GkR&tLOCK|@g%p$30B
West Pharmaceutical Services Inc
WST
LOCK|K>Bks^@bLOCK|XS$25B
The Cooper Companies Inc
COO
LOCK|Z>pLCSLOCK|#^ByM$14B
Align Technology Inc
ALGN
LOCK|Ff?hC#>LOCK|@QW%v$13B
Baxter International Inc
BAX
LOCK|<CLOCK|!??Xx$12B

Sponsor Center